BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2819727)

  • 1. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy.
    Wang JC
    NCI Monogr; 1987; (4):3-6. PubMed ID: 2819727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.
    Boege F
    Eur J Clin Chem Clin Biochem; 1996 Nov; 34(11):873-88. PubMed ID: 8960461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple bacterial topoisomerases: specialization or redundancy?
    Schmid MB; Sawitzke JA
    Bioessays; 1993 Jul; 15(7):445-9. PubMed ID: 8397515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA topoisomerases and topoisomerase inhibitors.
    Giaccone G
    Pathol Biol (Paris); 1994 Apr; 42(4):346-52. PubMed ID: 7808789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR; Foster SR; Maxwell A
    J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).
    Withoff S; De Jong S; De Vries EG; Mulder NH
    Anticancer Res; 1996; 16(4A):1867-80. PubMed ID: 8712715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological function of DNA topoisomerases and its implication in cancer chemotherapy].
    Andoh T; Okada K; Oguro M
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):1-14. PubMed ID: 2827584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topoisomerase II as a target for anticancer chemotherapy.
    Kaufmann SH; Hancock R
    Acta Biochim Pol; 1995; 42(4):381-93. PubMed ID: 8852329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.
    Mao Y; Yu C; Hsieh TS; Nitiss JL; Liu AA; Wang H; Liu LF
    Biochemistry; 1999 Aug; 38(33):10793-800. PubMed ID: 10451375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide sequencing and site-directed mutagenesis identify tyrosine-319 as the active site tyrosine of Escherichia coli DNA topoisomerase I.
    Lynn RM; Wang JC
    Proteins; 1989; 6(3):231-9. PubMed ID: 2560190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for tumor cell killing by topoisomerase poisons.
    Zhang H; D'Arpa P; Liu LF
    Cancer Cells; 1990 Jan; 2(1):23-7. PubMed ID: 2167111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase dysfunction: a new goal for antitumor chemotherapy.
    Smith PJ
    Bioessays; 1990 Apr; 12(4):167-72. PubMed ID: 2159289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the structure of eukaryotic topoisomerase II.
    Lee MP; Hsieh TS
    J Mol Biol; 1994 Jan; 235(2):436-47. PubMed ID: 8289273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topoisomerase I cleavage site in the regulatory zone of transcriptionally active minichromosomes of the SV40 virus located adjacent to a region, hypersensitive to DNAase I and segments recognizing topoisomerase II].
    Vasetskiĭ ES; Kalandadze AG; Razin SV; Georgiev GP
    Dokl Akad Nauk SSSR; 1989; 306(6):1493-6. PubMed ID: 2553371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.